Hyperkalemia, or high potassium, poses a significant threat, especially for individuals with chronic kidney disease or heart ...

Amicus licenses exclusive U.S. rights to commercialize DMX-200 for the treatment of Focal Segmental Glomerulosclerosis (FSGS) DMX-200 is in a pivotal Phase 3 trial for FSGS, a rare and fatal kidney ...

Following a meeting with the US FDA, clinical-stage biotech Dimerix has confirmed the appropriate primary endpoint for full ...

The US FDA has confirmed proteinuria as an acceptable primary endpoint in Dimerix ‘s Phase III ACTION3 trial of DMX-200 for ...

CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) are pleased to announce that the European Commission has approved ...

New research shows exercise could blunt alcohol’s damaging impact on the body, adding to evidence linking consumption to long ...

Aishwarya is seen looking visibly tense while standing next to Abhishek in the viral video, which has sparked fresh discussion among fans.

Amitabh, Abhishek, Aishwarya, Aaradhya, lekin uske baad kya?' Riteish Deshmukh's question left Abhishek Bachchan stunned. Check out his reply.

Recent research from the Fred Hutchinson Cancer Center is showing some promising findings in dosage that could be a game changer. The vaccine, known as Gardasil, has been given to millions of ...

author of ‘Fearless Speech,’ but “courage can be contagious, even if it’s in really small doses.”April 19, 2025 ...

Though the renal protection provided by antihypertensive doses of ACE inhibitors and ARBs has been extensively studied, the dose response of these agents may be different for renal protection.

The NHS says taking too high a dose of lercanidipine can make you feel dizzy and sleepy. The alert from the MHRA said on Thursday that it was informed by Italian pharmaceutical firm Recordati that ...